Explore how S-trityl-L-cysteine (STLC) and its analogs target cancer cells during mitosis by inhibiting Eg5 motor protein, offering precision cancer therapy with reduced side effects.
Discover how NQO1, once thought to be a simple cellular detoxifier, plays a critical role in cell division and its implications for cancer therapy.